108 related articles for article (PubMed ID: 28035058)
21. Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling.
Sabzichi M; Hamishehkar H; Ramezani F; Sharifi S; Tabasinezhad M; Pirouzpanah M; Ghanbari P; Samadi N
Asian Pac J Cancer Prev; 2014; 15(13):5311-6. PubMed ID: 25040994
[TBL] [Abstract][Full Text] [Related]
22. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
[TBL] [Abstract][Full Text] [Related]
23. NRF2 and the Hallmarks of Cancer.
Rojo de la Vega M; Chapman E; Zhang DD
Cancer Cell; 2018 Jul; 34(1):21-43. PubMed ID: 29731393
[TBL] [Abstract][Full Text] [Related]
24. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
[TBL] [Abstract][Full Text] [Related]
26. MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
Xiang Y; Liao XH; Yao A; Qin H; Fan LJ; Li JP; Hu P; Li H; Guo W; Li JY; Gu CJ; Bao LY; Zhang TC
Exp Cell Res; 2017 Oct; 359(2):394-404. PubMed ID: 28822708
[TBL] [Abstract][Full Text] [Related]
27. miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.
Shi L; Chen ZG; Wu LL; Zheng JJ; Yang JR; Chen XF; Chen ZQ; Liu CL; Chi SY; Zheng JY; Huang HX; Lin XY; Zheng F
Asian Pac J Cancer Prev; 2014; 15(23):10439-44. PubMed ID: 25556489
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation.
Li T; Liu Z; Jiang K; Ruan Q
Cancer Lett; 2013 Sep; 337(2):276-84. PubMed ID: 23643942
[TBL] [Abstract][Full Text] [Related]
29. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
[TBL] [Abstract][Full Text] [Related]
30. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.
Salaroglio IC; Panada E; Moiso E; Buondonno I; Provero P; Rubinstein M; Kopecka J; Riganti C
Mol Cancer; 2017 May; 16(1):91. PubMed ID: 28499449
[TBL] [Abstract][Full Text] [Related]
31. MRTF-A mediates the activation of COL1A1 expression stimulated by multiple signaling pathways in human breast cancer cells.
Meng C; He Y; Wei Z; Lu Y; Du F; Ou G; Wang N; Luo XG; Ma W; Zhang TC; He H
Biomed Pharmacother; 2018 Aug; 104():718-728. PubMed ID: 29807221
[TBL] [Abstract][Full Text] [Related]
32. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.
Manandhar S; Lee S; Kwak MK
Arch Pharm Res; 2010 May; 33(5):717-26. PubMed ID: 20512470
[TBL] [Abstract][Full Text] [Related]
33. miR‑144‑3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2.
Yin Y; Liu H; Xu J; Shi D; Zhai L; Liu B; Wang L; Liu G; Qin J
Oncol Rep; 2018 Dec; 40(6):3479-3488. PubMed ID: 30542710
[TBL] [Abstract][Full Text] [Related]
34. SRF'ing and SAP'ing - the role of MRTF proteins in cell migration.
Gau D; Roy P
J Cell Sci; 2018 Oct; 131(19):. PubMed ID: 30309957
[TBL] [Abstract][Full Text] [Related]
35. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
Gao AM; Ke ZP; Shi F; Sun GC; Chen H
Chem Biol Interact; 2013 Oct; 206(1):100-8. PubMed ID: 23994249
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional factors p300 and MRTF-A synergistically enhance the expression of migration-related genes in MCF-7 breast cancer cells.
He H; Wang D; Yao H; Wei Z; Lai Y; Hu J; Liu X; Wang Y; Zhou H; Wang N; Luo XG; Zhang TC
Biochem Biophys Res Commun; 2015 Nov; 467(4):813-20. PubMed ID: 26476216
[TBL] [Abstract][Full Text] [Related]
37. Myocardin-related transcription factor-A promoting neuronal survival against apoptosis induced by hypoxia/ischemia.
Cao XL; Hu XM; Hu JQ; Zheng WX
Brain Res; 2011 Apr; 1385():263-74. PubMed ID: 21333636
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2.
Luo Y; Zhang W; Xu L; Chen Y; Xu Y; Yuan L
Technol Cancer Res Treat; 2020; 19():1533033820980763. PubMed ID: 33327894
[TBL] [Abstract][Full Text] [Related]
39. The protective role of Nrf2-Gadd45b against antimony-induced oxidative stress and apoptosis in HEK293 cells.
Jiang X; An Z; Lu C; Chen Y; Du E; Qi S; Yang K; Zhang Z; Xu Y
Toxicol Lett; 2016 Aug; 256():11-8. PubMed ID: 27208483
[TBL] [Abstract][Full Text] [Related]
40. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
